Pinpointing Brain TREM2 Levels in Two Mouse Models of Alzheimer's Disease.
Silvio R MeierDag SehlinGreta HultqvistStina SyvänenPublished in: Molecular imaging and biology (2021)
Antibody-based radioligands, engineered to enter the brain, may serve as PET radioligands to follow changes of TREM2 in vivo, but antibody formats with faster systemic clearance to increase the specific signal in relation to that from blood in combination with antibodies showing higher affinity for TREM2 must be developed to further progress this technique for in vivo use.